Ben-Maimon Carole

Avg. Two Year Performance

(84%) Avg. Purchase Return
(36%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return11%(7%)(9%)(17%)(84%)
Purchase Success Rate2 of 21 of 21 of 20 of 20 of 2
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

President and CEO, Director:

Holdings: 332.95K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

President, Global Pharm.:

Holdings: 85.91K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 16.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--